FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance-Reference-Cited by-同舟云学术

FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance

Published:2013-04-24 Issue:6 Volume:97 Page:683-694
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Grunwald Michael R.,Levis Mark J.

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-013-1334-8.pdf

Reference105 articles.

1. Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341:1051–62.

2. Buchner T, Schlenk RF, Schaich M, Döhner K, Krahl R, Krauter J, et al., et al. Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm—combined prospective analysis by the German AML Intergroup. J Clin Oncol. 2012;30:3604–10.

3. Marcucci G, Maharry K, Whitman SP, Vukosavljevic T, Paschka P, Langer C, et al. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol. 2007;25:3337–43.

4. Fröhling S, Schlenk RF, Breitruck J, Benner A, Kreitmeier S, Tobis K, et al. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm. Blood. 2002;100:4372–80.

5. Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia. 1996;10:1911–8.

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Docking-guided exploration of the anti-flt3 potential of isoindigo derivatives towards potential treatments of acute myeloid leukemia;Medicinal Chemistry Research;2024-06-17

2. Molecular hybridization: a powerful tool for multitarget drug discovery;Expert Opinion on Drug Discovery;2024-03-08

3. Oncogenic FLT3 internal tandem duplication activates E2F1 to regulate purine metabolism in acute myeloid leukaemia;Biochemical Pharmacology;2023-04

4. PROTACs: Walking through hematological malignancies;Frontiers in Pharmacology;2023-02-20

5. PCW-A1001, AI-assisted de novo design approach to design a selective inhibitor for FLT-3(D835Y) in acute myeloid leukemia;Frontiers in Molecular Biosciences;2022-11-25